Orasis Pharmaceuticals
Paul Smith was named president and chief operating officer of Israel-based Orasis in April of 2021. Prior to Orasis, Smith was the vice president and business unit head for the U.S. Eye Care pharmaceutical portfolio at Novartis. Previously, he served as executive vice president of global commercial operations for TearLab, after spending 12 years at Alcon.
This person is not in any offices
Orasis Pharmaceuticals
2 followers
Orasis is an emerging ophthalmic pharmaceutical company with the goal of making near vision clear again. They are committed to the Ophthalmology and Optometry segments because they know that presbyopia is ubiquitous. By virtue of their first in class formulation, Orasis is well-positioned to be first-line therapy in this emerging category by addressing a significant unmet need for patients.